Cannabinoid receptors: An update on cell signaling, pathophysiological roles and therapeutic opportunities in neurological, cardiovascular, and inflammatory …

D Haspula, MA Clark - International journal of molecular sciences, 2020 - mdpi.com
The identification of the human cannabinoid receptors and their roles in health and disease,
has been one of the most significant biochemical and pharmacological advancements to …

Endocannabinoid system in neurodegenerative disorders

BS Basavarajappa, M Shivakumar… - Journal of …, 2017 - Wiley Online Library
Most neurodegenerative disorders (NDD s) are characterized by cognitive impairment and
other neurological defects. The definite cause of and pathways underlying the progression …

Cannabinoid CB1 and CB2 Receptor Signaling and Bias

MS Ibsen, M Connor, M Glass - Cannabis and cannabinoid research, 2017 - liebertpub.com
An agonist that acts through a single receptor can activate numerous signaling pathways.
Recent studies have suggested that different ligands can differentially activate these …

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression

C Blázquez, M Salazar, A Carracedo, M Lorente… - Cancer research, 2008 - AACR
Cannabinoids, the active components of Cannabis sativa L. and their derivatives, inhibit
tumor growth in laboratory animals by inducing apoptosis of tumor cells and impairing tumor …

Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists

E Wouters, J Walraed, SD Banister, CP Stove - Biochemical pharmacology, 2019 - Elsevier
Abstract Cannabinoid receptors type 1 (CB 1) and type 2 (CB 2) are promising targets for a
number of diseases, including obesity, neuropathic pain, and multiple sclerosis, among …

Cannabinoids as immune system modulators: Cannabidiol potential therapeutic approaches and limitations

A Aziz, LC Nguyen, L Oumeslakht… - Cannabis and …, 2023 - liebertpub.com
Introduction: Cannabidiol (CBD) is the second most abundant Phytocannabinoid in
Cannabis extracts. CBD has a binding affinity for several cannabinoid and cannabinoid …

ERK activation pathways downstream of GPCRs

R Jain, U Watson, L Vasudevan, DK Saini - International review of cell and …, 2018 - Elsevier
Abstract GPCRs, the 7-TM receptors, represent a class of cell surface receptors which
modulate a variety of physiological responses. The serpentine structure in addition to …

Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias

JJ Manning, HM Green, M Glass, DB Finlay - Neuropharmacology, 2021 - Elsevier
The type-1 cannabinoid receptor (CB 1) is a promising drug target for a wide range of
diseases. However, many existing and novel candidate ligands for CB 1 have shown only …

Cannabinoid Receptor 2 (CB2) Signals via G-alpha-s and Induces IL-6 and IL-10 Cytokine Secretion in Human Primary Leukocytes

Y Saroz, DT Kho, M Glass, ES Graham… - ACS pharmacology & …, 2019 - ACS Publications
Cannabinoid receptor 2 (CB2) is a promising therapeutic target for immunological
modulation. There is, however, a deficit of knowledge regarding CB2 signaling and function …

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

NL Grimsey, CE Goodfellow, EL Scotter… - Journal of neuroscience …, 2008 - Elsevier
The study of endogenous cannabinoid CB1 receptor proteins in neuronal tissues and cells
relies on the availability of highly specific antibodies. We have tested the ability of a series of …